Showing results (11-20 of 149) with videos related to
Sort By:
Pageof 15
Blood Advances|November 8, 2019
Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitusSherif M Badawy, Amanda B PayneJMIR Mhealth and Uhealth|October 27, 2016
Economic Evaluation of Text-Messaging and Smartphone-Based Interventions to Improve Medication Adherence in Adolescents with Chronic Health Conditions: A Systematic ReviewSherif M Badawy, Lisa M KuhnsMhealth|August 5, 2022
Utility of Fitbit devices among children and adolescents with chronic health conditions: a scoping reviewAlexandra M Kasparian, Sherif M BadawyPediatric Health, Medicine and Therapeutics|January 5, 2022
Mental Health Implications of the COVID-19 Pandemic Among Children and Adolescents: What Do We Know so Far?Zoe I Listernick, Sherif M BadawyJournal of Blood Medicine|December 6, 2022
Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell DiseaseChristina M Barriteau, Sherif M BadawyJournal of Cardiovascular Development and Disease|July 2, 2021
Adherence to Immunosuppression Medications among Heart Transplant Recipients: Challenges, Opportunities, and Potential Role of Digital Approaches in the COVID-19 EraTasmeen Hussain, Keira Nassetta, Sherif M BadawyJMIR Pediatrics and Parenting|October 1, 2020
Psychosocial Challenges and Opportunities for Youth With Chronic Health Conditions During the COVID-19 PandemicAnna Serlachius, Sherif M Badawy, Hiran ThabrewExpert Review of Hematology|February 9, 2023
An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromesRicha Shah, Aashaka Shah, Sherif M BadawyBiomed Research International|July 28, 2022
Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic ReviewMira Yang, Lena Elmuti, Sherif M BadawyPharmacy (Basel, Switzerland)|October 26, 2022
Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamineMichael Migotsky, Molly Beestrum, Sherif M BadawyPageof 15